Osteo Bi-Flex Triple Strength with Vitamin D Glucosamine Chondroitin Joint Health Supplement 150 Coated Tablets

Osteo Bi-Flex Triple Strength with Vitamin D Glucosamine Chondroitin Joint Health Supplement 150 Coated Tablets

• Osteo Bi-Flex Triple Joint Health Supplements, Vitamin D and Glucosamine Chondroitin Tablets, 150 Count
• Joint Shield, to give your joints the nourishment they need
• Addition of Vitamin D to support bone density along with a healthy immune system
• Strengthens your joints and helps maintain flexibility and agility, so you’re always ready for action
• 2 coated tablets per day.

• Osteo Bi-Flex Triple Strength Joint Health Supplements, Vitamin D and Glucosamine Chondroitin Tablets,150 Count
• Shows Improved Joint Comfort within 7 Days†*
• #1 Pharmacist recommended brand
• Osteo Bi-Flex Joint Health Dietary Supplement helps strengthen your joints.*
• Includes Vitamin D to support bone density*
• The only leading brand with Joint Shield 5-Loxin Advanced (100 mg of Boswellia serrata Extract).
• * or (1) These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. 2 or (2) IRI Total US-Multi Outlet Latest 52 weeks ending 05/28/23. 1 or ◊ or (3) Based on the results of the U.S Pharmacy Times Survey of Pharmacists’ OTC Recommendations who recommend a “joint health” dietary supplement, 2023-2024. † or (4) Based on three human studies with 5-LOXIN ADVANCED® where subjects rated their joint health over time, subjects’ joint health improved within 7 days, and continued to improve throughout the duration of the studies. Δ or (5) Refers to level of Glucosamine HCl per tablet compared to regular strength. ‡ or (7) In a select study, participants taking Joint Shield (5-LOXIN ADVANCED®) or placebo over 90 days rated their joint comfort during daily activities. Individual results may vary. 5-LOXIN ADVANCED® is a registered trademark of PLT Health Solutions – Laila Nutraceuticals, LLC. U.S. Patent #8,551,496 and patents pending.